• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2023

Year: 2023

Stock News

Graham Corporation 2023 Q3 – Results – Earnings Call Presentation (NYSE:GHM)

February 6, 2023 admin 0

This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and […]

Stock News

Tyson Foods, Inc. 2023 Q1 – Results – Earnings Call Presentation (NYSE:TSN)

February 6, 2023 admin 0

This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and […]

Stock News

Atlassian (TEAM): R&D Adjustments Reveal Profitability Boost

February 6, 2023 admin 0

Galeanu Mihai Atlassian (NASDAQ:TEAM) is an Australian-founded software company that has a mission to “unleash” the power of teams globally. The company’s product Jira was named a leader for agile software development teams by both […]

Posts navigation

« 1 … 1,477 1,478 1,479 … 4,581 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • S&P 500, Nasdaq, Dow Grind into Key Support
    September 6, 2022 0
  • Hibbett, Inc. (HIBB) Q2 2023 Earnings Call Transcript
    August 25, 2022 0
  • Interactive Brokers: Big Profits From Volatility (NASDAQ:IBKR)
    January 29, 2023 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.